BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16001973)

  • 1. Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways.
    Lehnhardt M; Klein-Hitpass L; Kuhnen C; Homann HH; Daigeler A; Steinau HU; Roehrs S; Schnoor L; Steinstraesser L; Mueller O
    BMC Cancer; 2005 Jul; 5():74. PubMed ID: 16001973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro‑apoptotic effects of pycnogenol on HT1080 human fibrosarcoma cells.
    Harati K; Slodnik P; Chromik AM; Behr B; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A
    Int J Oncol; 2015 Apr; 46(4):1629-36. PubMed ID: 25625225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol induces apoptosis and alters gene expression in human fibrosarcoma cells.
    Harati K; Slodnik P; Chromik AM; Goertz O; Hirsch T; Kapalschinski N; Klein-Hitpass L; Kolbenschlag J; Uhl W; Lehnhardt M; Daigeler A
    Anticancer Res; 2015 Feb; 35(2):767-74. PubMed ID: 25667456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-197-5p increases Doxorubicin-mediated anticancer cytotoxicity of HT1080 fibrosarcoma cells by decreasing drug efflux.
    Jain N; Das B; Mallick B
    DNA Repair (Amst); 2022 Jan; 109():103259. PubMed ID: 34871862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib inhibits proliferation of Ewing tumor cells mediated by the stem cell factor/KIT receptor pathway, and sensitizes cells to vincristine and doxorubicin-induced apoptosis.
    González I; Andreu EJ; Panizo A; Inogés S; Fontalba A; Fernández-Luna JL; Gaboli M; Sierrasesúmaga L; Martín-Algarra S; Pardo J; Prósper F; de Alava E
    Clin Cancer Res; 2004 Jan; 10(2):751-61. PubMed ID: 14760098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin.
    Bao Q; Niess H; Djafarzadeh R; Zhao Y; Schwarz B; Angele MK; Jauch KW; Nelson PJ; Bruns CJ
    Target Oncol; 2014 Sep; 9(3):251-61. PubMed ID: 23934106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line.
    Hochhauser D; Schnieders B; Ercikan-Abali E; Gorlick R; Muise-Helmericks R; Li WW; Fan J; Banerjee D; Bertino JR
    J Natl Cancer Inst; 1996 Sep; 88(18):1269-75. PubMed ID: 8797766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
    Stucke-Ring J; Ronnacker J; Brand C; Höltke C; Schliemann C; Kessler T; Schmidt LH; Harrach S; Mantke V; Hintelmann H; Hartmann W; Wardelmann E; Lenz G; Wünsch B; Müller-Tidow C; Mesters RM; Schwöppe C; Berdel WE
    Oncotarget; 2016 Dec; 7(50):82458-82472. PubMed ID: 27738341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The time-dependent serial gene response to Zeocin treatment involves caspase-dependent apoptosis in HeLa cells.
    Hwang J; Kim YY; Huh S; Shim J; Park C; Kimm K; Choi DK; Park TK; Kim S
    Microbiol Immunol; 2005; 49(4):331-42. PubMed ID: 15840958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAIL and doxorubicin combination induces proapoptotic and antiangiogenic effects in soft tissue sarcoma in vivo.
    Wang S; Ren W; Liu J; Lahat G; Torres K; Lopez G; Lazar AJ; Hayes-Jordan A; Liu K; Bankson J; Hazle JD; Lev D
    Clin Cancer Res; 2010 May; 16(9):2591-604. PubMed ID: 20406839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronidase induces murine L929 fibrosarcoma cells resistant to tumor necrosis factor and Fas cytotoxicity in the presence of actinomycin D.
    Chang NS
    Cell Biochem Biophys; 1995-1996; 27(2):109-32. PubMed ID: 9106395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.
    Daigeler A; Brenzel C; Bulut D; Geisler A; Hilgert C; Lehnhardt M; Steinau HU; Flier A; Steinstraesser L; Klein-Hitpass L; Mittelkötter U; Uhl W; Chromik AM
    J Exp Clin Cancer Res; 2008 Dec; 27(1):82. PubMed ID: 19077262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
    Koto K; Murata H; Kimura S; Horie N; Matsui T; Nishigaki Y; Ryu K; Sakabe T; Itoi M; Ashihara E; Maekawa T; Fushiki S; Kubo T
    Oncol Rep; 2010 Jul; 24(1):233-9. PubMed ID: 20514467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
    Thomadaki H; Scorilas A
    Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells.
    Harati K; Chromik AM; Bulut D; Goertz O; Hahn S; Hirsch T; Klein-Hitpass L; Lehnhardt M; Uhl W; Daigeler A
    Anticancer Res; 2012 Jul; 32(7):2967-84. PubMed ID: 22753761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actinomycin D synergistically enhances the efficacy of the BH3 mimetic ABT-737 by downregulating Mcl-1 expression.
    Olberding KE; Wang X; Zhu Y; Pan J; Rai SN; Li C
    Cancer Biol Ther; 2010 Nov; 10(9):918-29. PubMed ID: 20818182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; Vessella B; Zangemeister-Wittke U; Gleave ME
    Mol Cancer Ther; 2005 Nov; 4(11):1689-98. PubMed ID: 16275990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
    Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
    Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.